CRSP — Crispr Therapeutics AG Namen Akt Institutional Holders · Q3 2026
Who owns Crispr Therapeutics AG Namen Akt (CRSP)? 14 institutions reported holding $11.40M in SEC 13F filings for Q3 2026 (period ended 2026-09-30). Largest holders: Congress Asset Management Co ($6.2M), Green Alpha Advisors, LLC ($3.1M), Wealth Enhancement Trust Services, Inc. ($1.1M).
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | CONGRESS ASSET MANAGEMENT CO | $6.2M | 111,230 | Added |
| 2 | Green Alpha Advisors, LLC | $3.1M | 56,786 | Added |
| 3 | Wealth Enhancement Trust Services, Inc. | $1.1M | 20,097 | Trimmed |
| 4 | Farther Finance Advisors, LLC | $632,105 | 11,426 | Added |
| 5 | Valeo Financial Advisors, LLC | $201,144 | 3,636 | Trimmed |
| 6 | GAMMA Investing LLC | $68,929 | 1,246 | Added |
| 7 | Versant Capital Management, Inc | $59,635 | 1,078 | Added |
| 8 | Pacifica Partners Inc. | $11,086 | 200 | Added |
| 9 | CX Institutional | $9,000 | 164 | Trimmed |
| 10 | Hickory Point Bank & Trust | $8,298 | 150 | Hold |
| 11 | CoreCap Advisors, LLC | $5,477 | 99 | Hold |
| 12 | TOTH FINANCIAL ADVISORY CORP | $2,213 | 40 | Hold |
| 13 | MassMutual Private Wealth & Trust, FSB | $443 | 8 | Hold |
| 14 | Paladin Partners, LLC | $0 | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-09-30